Pneumoconiosis cost-effectiveness of therapy

Pneumoconiosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pneumoconiosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pneumoconiosis cost-effectiveness of therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pneumoconiosis cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pneumoconiosis cost-effectiveness of therapy
CDC on Pneumoconiosis cost-effectiveness of therapy
Pneumoconiosis cost-effectiveness of therapy in the news
Blogs on Pneumoconiosis cost-effectiveness of therapy
Directions to Hospitals Treating Pneumoconiosis
Risk calculators and risk factors for Pneumoconiosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD

Overview

The most cost-effective method to prevent pneumoconiosis is avoidance of exposure through primary and secondary prevention.

Cost-effectiveness of Therapy

This includes education, behavioral changes, strict regulations and adherence at workplaces, smoking cessation and vaccination against influenza and pneumococcus.